Abstract
The ductus arteriosus is a muscular artery connecting two elastic arteries with different resistances. It is a normal fetal structure that only becomes pathological if it remains patent after birth. A varied clinical impact is observed as some neonates may be asymptomatic, symptoms may be deferred until later in life, or the infant may be overtly symptomatic and present as early as the first days of life. Prematurity increases the likelihood of persistent ductal patency and is seen in about 30% of preterm infants. In premature neonates, patent ductus arteriosus (PDA) is associated with significant morbidity and mortality [1,2]. This discussion explains the pathophysiology behind the pathological events associated with PDA.
Keywords: Patent ductus arteriosus, extremely premature neonate, pathophysiology, pulmonary blood flow.
Current Pediatric Reviews
Title:Pathophysiology of Patent Ductus Arteriosus in the Preterm Infant
Volume: 12 Issue: 2
Author(s): Joseph J. Vettukattil
Affiliation:
Keywords: Patent ductus arteriosus, extremely premature neonate, pathophysiology, pulmonary blood flow.
Abstract: The ductus arteriosus is a muscular artery connecting two elastic arteries with different resistances. It is a normal fetal structure that only becomes pathological if it remains patent after birth. A varied clinical impact is observed as some neonates may be asymptomatic, symptoms may be deferred until later in life, or the infant may be overtly symptomatic and present as early as the first days of life. Prematurity increases the likelihood of persistent ductal patency and is seen in about 30% of preterm infants. In premature neonates, patent ductus arteriosus (PDA) is associated with significant morbidity and mortality [1,2]. This discussion explains the pathophysiology behind the pathological events associated with PDA.
Export Options
About this article
Cite this article as:
J. Vettukattil Joseph, Pathophysiology of Patent Ductus Arteriosus in the Preterm Infant, Current Pediatric Reviews 2016; 12 (2) . https://dx.doi.org/10.2174/157339631202160506002215
DOI https://dx.doi.org/10.2174/157339631202160506002215 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mechanisms Involved in the Genesis of Diabetic Nephropathy
Current Diabetes Reviews Do We Need More Research on Platelet Function in South Asian Immigrants?
Inflammation & Allergy - Drug Targets (Discontinued) Subject Index To Volume 6
Current Molecular Medicine Anti-Bacterial Drug Discovery Using Systems Biology
Mini-Reviews in Medicinal Chemistry Hypertension: Basics Concepts and the Evolving Role of Novel Treatments
Current Hypertension Reviews The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators
CNS & Neurological Disorders - Drug Targets Fibrosis as a Therapeutic Target Post-Myocardial Infarction
Current Pharmaceutical Design Nitric Oxide and Protection against Cardiac Ischemia
Current Pharmaceutical Design Prevention of Respiratory Syncytial Virus: A Review
Current Respiratory Medicine Reviews Management of Peyronie's Disease after Collagenase (Xiaflex:<sup>®</sup>)
Current Drug Targets Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine
Current Pharmacogenomics and Personalized Medicine Side Effects of Atypical Antipsychotic Drugs
Current Pharmaceutical Design Nuclear Magnetic Resonance Spectroscopy and Genetic Disorders
Current Medicinal Chemistry Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets Congenital Duodenal Obstruction: The Impact of Downs Syndrome in Neonatal Morbidity. A Two-Center Survey
Current Pediatric Reviews Cardiovascular Magnetic Resonance Imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis
Inflammation & Allergy - Drug Targets (Discontinued) The Pluripotential Effects of Hypolipidemic Treatment for Polycystic Ovary Syndrome (PCOS): Dyslipidemia, Cardiovascular Risk Factors and Beyond
Current Pharmaceutical Design The Adiponectin Signaling Pathway as a Novel Pharmacological Target
Mini-Reviews in Medicinal Chemistry Mechanisms of Beta-Blockers Action in Patients with Heart Failure
Reviews on Recent Clinical Trials Impact of Pre-Diabetes and Diabetes on Cardiovascular Outcomes
Current Vascular Pharmacology